These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

458 related items for PubMed ID: 28440679

  • 1. Cervical cancer in sub-Saharan Africa: a preventable noncommunicable disease.
    Mboumba Bouassa RS, Prazuck T, Lethu T, Jenabian MA, Meye JF, Bélec L.
    Expert Rev Anti Infect Ther; 2017 Jun; 15(6):613-627. PubMed ID: 28440679
    [Abstract] [Full Text] [Related]

  • 2. Cervical cancer in sub-Saharan Africa: an emerging and preventable disease associated with oncogenic human papillomavirus.
    Mboumba Bouassa RS, Prazuck T, Lethu T, Meye JF, Bélec L.
    Med Sante Trop; 2017 Feb 01; 27(1):16-22. PubMed ID: 28406406
    [Abstract] [Full Text] [Related]

  • 3. Prevention of human papillomavirus (HPV)-related tumors in people living with human immunodeficiency virus (HIV).
    Poljak M, Šterbenc A, Lunar MM.
    Expert Rev Anti Infect Ther; 2017 Nov 01; 15(11):987-999. PubMed ID: 29027811
    [Abstract] [Full Text] [Related]

  • 4. Model-based impact and cost-effectiveness of cervical cancer prevention in sub-Saharan Africa.
    Kim JJ, Campos NG, O'Shea M, Diaz M, Mutyaba I.
    Vaccine; 2013 Dec 29; 31 Suppl 5():F60-72. PubMed ID: 24331749
    [Abstract] [Full Text] [Related]

  • 5. Human papillomavirus distribution in invasive cervical carcinoma in sub-Saharan Africa: could HIV explain the differences?
    Ndiaye C, Alemany L, Ndiaye N, Kamaté B, Diop Y, Odida M, Banjo K, Tous S, Klaustermeier JE, Clavero O, Castellsagué X, Bosch FX, Trottier H, de Sanjosé S.
    Trop Med Int Health; 2012 Dec 29; 17(12):1432-40. PubMed ID: 23107344
    [Abstract] [Full Text] [Related]

  • 6. Infrastructure requirements for human papillomavirus vaccination and cervical cancer screening in sub-Saharan Africa.
    Sankaranarayanan R, Anorlu R, Sangwa-Lugoma G, Denny LA.
    Vaccine; 2013 Dec 29; 31 Suppl 5():F47-52. PubMed ID: 24331747
    [Abstract] [Full Text] [Related]

  • 7. Trials and projects on cervical cancer and human papillomavirus prevention in sub-Saharan Africa.
    Adefuye PO, Broutet NJ, de Sanjosé S, Denny LA.
    Vaccine; 2013 Dec 29; 31 Suppl 5():F53-9. PubMed ID: 24331748
    [Abstract] [Full Text] [Related]

  • 8. The burden of human papillomavirus infections and related diseases in sub-saharan Africa.
    De Vuyst H, Alemany L, Lacey C, Chibwesha CJ, Sahasrabuddhe V, Banura C, Denny L, Parham GP.
    Vaccine; 2013 Dec 29; 31 Suppl 5(0 5):F32-46. PubMed ID: 24331746
    [Abstract] [Full Text] [Related]

  • 9. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.
    Rogovskaya SI, Shabalova IP, Mikheeva IV, Minkina GN, Podzolkova NM, Shipulina OY, Sultanov SN, Kosenko IA, Brotons M, Buttmann N, Dartell M, Arbyn M, Syrjänen S, Poljak M.
    Vaccine; 2013 Dec 31; 31 Suppl 7():H46-58. PubMed ID: 24332297
    [Abstract] [Full Text] [Related]

  • 10. Epidemiology and prevention of human papillomavirus and cervical cancer in sub-Saharan Africa: a comprehensive review.
    Louie KS, de Sanjose S, Mayaud P.
    Trop Med Int Health; 2009 Oct 31; 14(10):1287-302. PubMed ID: 19772550
    [Abstract] [Full Text] [Related]

  • 11. The prevention of cervical cancer in Africa.
    Fiander AN.
    Womens Health (Lond); 2011 Jan 31; 7(1):121-32. PubMed ID: 21175396
    [Abstract] [Full Text] [Related]

  • 12. Modelling the impact of prevention strategies on cervical cancer incidence in South Africa.
    van Schalkwyk C, Moodley J, Welte A, Johnson LF.
    Int J Cancer; 2021 Oct 15; 149(8):1564-1575. PubMed ID: 34164807
    [Abstract] [Full Text] [Related]

  • 13. Cervical cancer in sub-Saharan Africa: an urgent call for improving accessibility and use of preventive services.
    Dzinamarira T, Moyo E, Dzobo M, Mbunge E, Murewanhema G.
    Int J Gynecol Cancer; 2023 Apr 03; 33(4):592-597. PubMed ID: 36368710
    [Abstract] [Full Text] [Related]

  • 14. Cervical cancer: the sub-Saharan African perspective.
    Anorlu RI.
    Reprod Health Matters; 2008 Nov 03; 16(32):41-9. PubMed ID: 19027621
    [Abstract] [Full Text] [Related]

  • 15. Adolescent Health Series: HPV infection and vaccination in sub-Saharan Africa: 10 years of research in Tanzanian female adolescents - narrative review.
    Whitworth H, Changalucha J, Baisley K, Watson-Jones D.
    Trop Med Int Health; 2021 Nov 03; 26(11):1345-1355. PubMed ID: 34310816
    [Abstract] [Full Text] [Related]

  • 16. Planning for human papillomavirus (HPV) vaccination in sub-Saharan Africa: a modeling-based approach.
    Tracy JK, Schluterman NH, Greene C, Sow SO, Gaff HD.
    Vaccine; 2014 May 30; 32(26):3316-22. PubMed ID: 24731734
    [Abstract] [Full Text] [Related]

  • 17. Determining the HPV vaccine schedule for a HIV-infected population in sub Saharan Africa, a commentary.
    Menon S, Rossi R, Kariisa M, Callens S.
    Virol J; 2018 Aug 16; 15(1):129. PubMed ID: 30115083
    [Abstract] [Full Text] [Related]

  • 18. Developments in L2-based human papillomavirus (HPV) vaccines.
    Schellenbacher C, Roden RBS, Kirnbauer R.
    Virus Res; 2017 Mar 02; 231():166-175. PubMed ID: 27889616
    [Abstract] [Full Text] [Related]

  • 19. Human papillomavirus infection and related cancers in sub-Saharan Africa: burden and tools for prevention.
    Awolude OA, Morhason-Bello IO, Denny LA, Adewole IF.
    Vaccine; 2013 Dec 29; 31 Suppl 5():vii-x. PubMed ID: 24331751
    [No Abstract] [Full Text] [Related]

  • 20. Model-based impact and cost-effectiveness of cervical cancer prevention in the Extended Middle East and North Africa (EMENA).
    Kim JJ, Sharma M, O'Shea M, Sweet S, Diaz M, Sancho-Garnier H, Seoud M.
    Vaccine; 2013 Dec 30; 31 Suppl 6():G65-77. PubMed ID: 24331822
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.